Concepedia

Julia Coronella

JC

14

Publications

868

Citations

13

H-Index

2000

Active since

Affiliations

Poseida Therapeutics (United States)(Current)

University of California San Diego

Tanabe Research Laboratories

Pfizer (United States)

University of California, San Francisco

Julia Coronella is an author at Poseida Therapeutics (United States) specializing in immunology, tumor biology, and medicine.

Top concepts

Publications per year

2000–2023

14

Publications

14

Catalytic function of <i>Drosophila melanogaster</i> glutathione <i>S</i>‐transferase DmGSTS1‐1 (GST‐2) in conjugation of lipid peroxidation end products

Sharda P. Singh, Julia Coronella, Helen Beneš et al. · European Journal of Biochemistry · 2001 · 269 citations · Full text

Antigen-Driven Oligoclonal Expansion of Tumor-Infiltrating B Cells in Infiltrating Ductal Carcinoma of the Breast

Julia Coronella, Catherine Spier, Matthew Welch et al. · The Journal of Immunology · 2002 · 167 citations · Full text

Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.

Julia Coronella, Pieter Telleman, Gillian A. Kingsbury et al. · PubMed · 2001 · 88 citations

, , +15

TR1801‐ADC: a highly potent cMet antibody–drug conjugate with high activity in patient‐derived xenograft models of solid tumors

Marco Gymnopoulos, Oscar Betancourt, Vincent Blot et al. · Molecular Oncology · 2019 · 66 citations · Full text

Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells

Blair Madison, Deepak P. Patil, Maximilian Richter et al. · Molecular Therapy — Nucleic Acids · 2022 · 55 citations · Full text

Rows per page

1–5 of 14